Indication
Immune Thrombocytopenia (ITP)
6 clinical trials
8 products
Clinical trial
An Open-label, Multi-center, Phase 2 Basket Study to Assess Efficacy, Safety and Pharmacokinetics of Iptacopan (LNP023) in Participants With Autoimmune Benign Hematological DisordersStatus: Active (not recruiting), Estimated PCD: 2023-09-20
Product
IptacopanProduct
EltrombopagClinical trial
A Phase II, Randomized (1:1) Open Label Study to Assess the Efficacy and Safety of Eltrombopag in Combination With Dexamethasone Compared to Dexamethasone, as First-line Treatment in Adult Patients With Newly Diagnosed Immune ThrombocytopeniaStatus: Completed, Estimated PCD: 2023-09-22
Product
DexamethasoneClinical trial
A Multicenter, Phase 2a, Open-label, Non-randomized Study Evaluating the Efficacy, Safety, and Tolerability of BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2022-02-15
Product
SAR445088Clinical trial
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2017-08-01
Product
RomiplostimClinical trial
Phase 1b Open-label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)Status: Not yet recruiting, Estimated PCD: 2026-06-30
Product
RAY121Clinical trial
Intravenous Immunoglobulin Plus Oral Prednisone or High-dose Dexamethasone, for Adults With Immune Thrombocytopenia (ITP) With Moderate and Severe Bleeding: a Randomized, Multicentre TrialStatus: Recruiting, Estimated PCD: 2025-04-09
Product
Neofordex®Product
Intravenous immunoglobulins